Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

DNTH

Dianthus Therapeutics (DNTH)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DNTH
DataOraFonteTitoloSimboloCompagnia
30/01/202513:00GlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentations at Two Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
08/01/202513:00GlobeNewswire Inc.Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
07/11/202422:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
04/11/202413:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor ConferencesNASDAQ:DNTHDianthus Therapeutics Inc
15/10/202413:00GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
04/09/202413:00GlobeNewswire Inc.Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in SeptemberNASDAQ:DNTHDianthus Therapeutics Inc
08/08/202422:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
28/06/202417:30GlobeNewswire Inc.Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)NASDAQ:DNTHDianthus Therapeutics Inc
12/06/202413:00GlobeNewswire Inc.Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)NASDAQ:DNTHDianthus Therapeutics Inc
30/05/202422:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
09/05/202422:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
08/05/202422:30GlobeNewswire Inc.Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care ConferenceNASDAQ:DNTHDianthus Therapeutics Inc
03/05/202422:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
11/04/202413:30GlobeNewswire Inc.Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual MeetingNASDAQ:DNTHDianthus Therapeutics Inc
21/03/202421:01GlobeNewswire Inc.Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial ResultsNASDAQ:DNTHDianthus Therapeutics Inc
07/03/202422:30GlobeNewswire Inc.Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:DNTHDianthus Therapeutics Inc
26/02/202413:00GlobeNewswire Inc.Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)NASDAQ:DNTHDianthus Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:DNTH
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network